FOx Biosystems

{
  "events": [
    {
      "kind": "capital_increase",
      "after_eur": 1518265.05,
      "delta_eur": 75060.34,
      "before_eur": 1443204.71,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "NV Limburgse Reconversie Maatschappij",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 3846,
          "contribution_amount_eur": 290410.31
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "CommV Heran Healthtech Fund I",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 3846,
          "contribution_amount_eur": 290410.31
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "Katholieke Universiteit Leuven",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 1470,
          "contribution_amount_eur": 110999.26
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "NV Gemma Frisius-Fonds KU Leuven",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 637,
          "contribution_amount_eur": 48099.68
        }
      ],
      "_arith_repair": "delta_capital_only",
      "share_emission": {
        "agio_eur": 664859.22,
        "share_form": "no_nominal_value",
        "share_class": "Bijkomende Bevoorrechte Aandelen",
        "n_new_shares": 9799,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 75.51
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": 739919.56,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    }
  ],
  "notary": {
    "name": "Hugo Kuijpers",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Leuven-Heverlee",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-08-09",
    "filing_date": "2024-08-07",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-07-16",
    "unanimous": true,
    "under_authorized_capital": false,
    "underlying_resolution_date": "2024-07-16"
  },
  "bedrijfsrevisor": {
    "waived": true,
    "firm_kbo": null,
    "firm_name": "BV Finvision Bedrijfsrevisoren Antwerpen",
    "ibr_number": null,
    "mission_type": "none",
    "individual_name": "Karel Nijs"
  },
  "subject_company": {
    "kbo": "0653.744.366",
    "name_full": "FOx Biosystems",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "uitgifte van het proces-verbaal van buitengewone algemene vergadering",
    "geco\u00F6rdineerde statuten",
    "bijzondere verslagen van het bestuursorgaan",
    "verslagen van de commissaris"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "NV Limburgse Reconversie Maatschappij",
      "role": "aandeelhouder",
      "n_shares": 3846,
      "share_class": "Bijkomende Bevoorrechte Aandelen"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "CommV Heran Healthtech Fund I",
      "role": "aandeelhouder",
      "n_shares": 3846,
      "share_class": "Bijkomende Bevoorrechte Aandelen"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "Katholieke Universiteit Leuven",
      "role": "aandeelhouder",
      "n_shares": 1470,
      "share_class": "Bijkomende Bevoorrechte Aandelen"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "NV Gemma Frisius-Fonds KU Leuven",
      "role": "aandeelhouder",
      "n_shares": 637,
      "share_class": "Bijkomende Bevoorrechte Aandelen"
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 39730,
      "class_name": "Gewone Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 132090,
      "class_name": "Bevoorrechte Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 26415,
      "class_name": "Bijkomende Bevoorrechte Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jerry Williamson",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": false,
      "effective_date": "2024-01-01",
      "evidence_quote": "De algemene vergadering beslist als nieuwe onafhankelijke bestuurder te benoemen: Jerry Williamson. Zijn mandaat gaat in op 01/01/2024 en heeft een onbepaalde duur.",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "future"
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "vaste_vertegenwoordiger",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "PKF BOFIDI Accountants \u0026 Advisers",
        "address": "Cantersteen 47 - Central Gate, 1000 Brussels",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Bij deze wordt volmacht verleend voor onbepaalde tijd aan de BV PKF BOFIDI Accountants \u0026 Advisers, Cantersteen 47 - Central Gate, 1000 Brussels of aan \u00E9\u00E9n van haar lasthebbers, met name, mevrouw Lindsey Schamp, mevrouw Lisa Kennis, mevrouw Sylvia Vanbeveren, mevrouw Eva Thielemans, mevrouw Ellen Car",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2024-07-18",
    "act_kind_objet": "BENOEMING"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2024-06-28",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0653.744.366",
    "name_full": "FOX BIOSYSTEMS",
    "legal_form": "NAAMLOZE VENNOOTSCHAP",
    "_kbo_filled_from_list": true
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Sylvia Vanbeveren",
    "org_rep_person_name": null,
    "person_role_at_subject": "Gevolmachtigde"
  },
  "co_filed_documents": [
    "notulen van de algemene vergadering dd. 28/06/2024"
  ],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 1219041.44,
      "delta_eur": 23030.54,
      "before_eur": 1196010.9,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "NV Limburgse Reconversie Maatschappij",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "schuldvordering",
          "n_shares_subscribed": 1299,
          "contribution_amount_eur": 98087.1
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "KU Leuven",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "schuldvordering",
          "n_shares_subscribed": 711,
          "contribution_amount_eur": 53687.4
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "CommV Heran Healthtech Fund I",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "schuldvordering",
          "n_shares_subscribed": 1299,
          "contribution_amount_eur": 98087.1
        }
      ],
      "_arith_repair": "delta_capital_only",
      "share_emission": {
        "agio_eur": 226831.06,
        "share_form": "no_nominal_value",
        "share_class": "Bijkomende Bevoorrechte Aandelen",
        "n_new_shares": 3309,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 75.51
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 1298301.6,
      "delta_eur": 79260.16,
      "before_eur": 1219041.44,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "NV Limburgse Reconversie Maatschappij",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 4470,
          "contribution_amount_eur": 337528.36
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "CommV Heran Healthtech Fund I",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 4470,
          "contribution_amount_eur": 337528.36
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "Katholieke Universiteit Leuven",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 1493,
          "contribution_amount_eur": 112735.98
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "NV Gemma Frisius-Fonds KU Leuven",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 955,
          "contribution_amount_eur": 72111.76
        }
      ],
      "_arith_repair": "delta_capital_only",
      "share_emission": {
        "agio_eur": 780644.3,
        "share_form": "no_nominal_value",
        "share_class": "Bijkomende Bevoorrechte Aandelen",
        "n_new_shares": 11388,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 75.51
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 1443204.71,
      "delta_eur": 144903.11,
      "before_eur": 1298301.6,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "TrueLife Science Consulting Limited",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 14.98948,
          "contribution_kind": "geld",
          "n_shares_subscribed": 794,
          "contribution_amount_eur": 59954.7
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "BV Confluence Consulting",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 6.24843,
          "contribution_kind": "geld",
          "n_shares_subscribed": 331,
          "contribution_amount_eur": 24993.71
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "BV L.E.A.F. Management",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 8.74025,
          "contribution_kind": "geld",
          "n_shares_subscribed": 463,
          "contribution_amount_eur": 34960.99
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "BioBiz Ltd",
          "share_class": "Bijkomende Bevoorrechte Aandelen",
          "liberation_pct": 6.2494,
          "contribution_kind": "geld",
          "n_shares_subscribed": 331,
          "contribution_amount_eur": 24993.71
        }
      ],
      "share_emission": {
        "agio_eur": null,
        "share_form": "no_nominal_value",
        "share_class": "Bijkomende Bevoorrechte Aandelen",
        "n_new_shares": 1919,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 75.51
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Hugo Kuijpers",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Leuven-Heverlee",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-05-13",
    "filing_date": "2024-05-08",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2024-04-26",
    "unanimous": true,
    "under_authorized_capital": true,
    "underlying_resolution_date": "2024-04-10"
  },
  "bedrijfsrevisor": {
    "waived": false,
    "firm_kbo": null,
    "firm_name": "BV Finvision Bedrijfsrevisoren Antwerpen",
    "ibr_number": null,
    "mission_type": "quasi_apport",
    "individual_name": "Karel Nijs"
  },
  "subject_company": {
    "kbo": "0653.744.366",
    "name_full": "FOx Biosystems",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "expedition",
    "plan financier",
    "bankattest",
    "verslag bedrijfsrevisor"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "NV Limburgse Reconversie Maatschappij",
      "role": null,
      "n_shares": null,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "KU Leuven",
      "role": null,
      "n_shares": null,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "CommV Heran Healthtech Fund I",
      "role": null,
      "n_shares": null,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "TrueLife Science Consulting Limited",
      "role": null,
      "n_shares": null,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "BV Confluence Consulting",
      "role": null,
      "n_shares": null,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "BV L.E.A.F. Management",
      "role": null,
      "n_shares": null,
      "share_class": null
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "NV Gemma Frisius-Fonds KU Leuven",
      "role": null,
      "n_shares": null,
      "share_class": null
    }
  ],
  "share_classes_after": [
    {
      "n_shares": 39730,
      "class_name": "Gewone Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 132090,
      "class_name": "Bevoorrechte Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": 16616,
      "class_name": "Bijkomende Bevoorrechte Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}

{
  "events": [
    {
      "kind": "decharge_granted",
      "role": "commissaris",
      "person": null,
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "BV Finvision Bedrijfsrevisoren Antwerpen",
        "address": "Potvlietlaan 4, 2600 Berchem-Antwerpen",
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "De algemene vergadering ontslaat de voorzitter van de voorlezing van -de bijzondere verslagen van het bestuursorgaan, en -de verslagen van de commissaris, te weten de BV Finvision Bedrijfsrevisoren Antwerpen, met zetel te 2600 Berchem-Antwerpen, Potvlietlaan 4, vertegenwoordigd door de heer Karel Ni",
      "decharge_status": "granted",
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Filip Delport",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2024-01-29",
      "evidence_quote": "6. De algemene vergadering gaat over tot de herbenoeming, met ingang van 29/01/2024, van volgende bestuurders, en dit voor de duur van 6 jaar: 1) de heer Filip Delport;",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "board_snapshot",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Jeroen Lammertyn",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2024-01-29",
      "evidence_quote": "6. De algemene vergadering gaat over tot de herbenoeming, met ingang van 29/01/2024, van volgende bestuurders, en dit voor de duur van 6 jaar: 1) de heer Filip Delport; 2) de heer Jeroen Lammertyn;",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "board_snapshot",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Bart Geers",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2024-01-29",
      "evidence_quote": "6. De algemene vergadering gaat over tot de herbenoeming, met ingang van 29/01/2024, van volgende bestuurders, en dit voor de duur van 6 jaar: 1) de heer Filip Delport; 2) de heer Jeroen Lammertyn; 3) de heer Bart Geers;",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "board_snapshot",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Dries Bauters",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": "0440.550.442",
        "name": "NV LRM Beheer",
        "address": null,
        "country": "BE",
        "legal_form": "NV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "6. De algemene vergadering gaat over tot de herbenoeming, met ingang van 29/01/2024, van volgende bestuurders, en dit voor de duur van 6 jaar: 4) de NV LRM Beheer (0440.550.442), met vaste vertegenwoordiger de heer Dries Bauters;",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "board_snapshot",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mark Truesdale",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": "statutair",
      "compensated": null,
      "effective_date": "2024-01-29",
      "evidence_quote": "6. De algemene vergadering gaat over tot de herbenoeming, met ingang van 29/01/2024, van volgende bestuurders, en dit voor de duur van 6 jaar: 5) de heer Mark Truesdale als bestuurder \u00E9n persoon belast met het dagelijks bestuur,",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "n_years",
        "value": "6"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": "immediate"
    },
    {
      "kind": "board_snapshot",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Katleen Vandersmissen",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "BV Heran Partners",
        "address": null,
        "country": "BE",
        "legal_form": "BV"
      },
      "statutory": "statutair",
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "6. De algemene vergadering gaat over tot de herbenoeming, met ingang van 29/01/2024, van volgende bestuurders, en dit voor de duur van 6 jaar: 6) de BV Heran Partners, met vaste vertegenwoordiger mevrouw Katleen Vandersmissen.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": "Hugo Kuijpers",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Leuven-Heverlee",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2024-05-13",
    "filing_date": "2024-05-08",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "buitengewone_algemene_vergadering",
      "date": "2024-04-26",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0653.744.366",
    "name_full": "FOx Biosystems",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "uitgifte van het proces-verbaal van buitengewone algemene vergadering",
    "geco\u00F6rdineerde statuten",
    "voornoemde bijzondere verslagen van het bestuursorgaan",
    "voornoemde verslagen van de commissaris"
  ],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mark Truesdale",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "coopted",
      "compensated": false,
      "effective_date": "2023-09-01",
      "evidence_quote": "De vergadering besluit unaniem om de heer Mark Truesdale te benoemen tot persoon belast met het dagelijks bestuur van de vennootschap (CEO), ter vervanging van Thomas Van Elzakker (Vithea BV) in deze functie met ingang van 01/09/2023.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Thomas Van Elzakker",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": {
        "kbo": null,
        "name": "Vithea BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "statutory": "coopted",
      "compensated": null,
      "effective_date": "2023-09-01",
      "evidence_quote": "De vergadering heeft de ontslagbrief van Vithea BV, vertegenwoordigd door haar vaste vertegenwoordiger, Thomas Van Elzakker, ontvangen. Hierin neemt hij ontslag als bestuurder en CEO van de NV met ingang van 01/09/2023.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mark Truesdale",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "renewal",
      "via_org": null,
      "statutory": "coopted",
      "compensated": false,
      "effective_date": "2023-09-01",
      "evidence_quote": "De vergadering aanvaardt het ontslag van Vithea BV (Thomas Van Elzakker) en besluit om de heer Mark Truesdale met ingang van 01/09/2023 door co\u00F6ptatie te benoemen tot bestuurder, om het vacant geworden bestuurdersmandaat te vervolledigen.",
      "decharge_status": null,
      "mandate_duration": null,
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": null,
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2023-11-28",
    "act_kind_objet": "ONTSLAG - BENOEMING"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2023-09-15",
      "unanimous": true
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0653.744.366",
    "name_full": "FOx Biosystems",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Limdsey Schamp",
    "org_rep_person_name": null,
    "person_role_at_subject": "Gevolmachtigde"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Finvision Bedrijfsrevisoren Antwerpen BV",
        "address": "Potvlietlaan 4, 2600 Berchem-Antwerpen",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": null,
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": "2026"
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Lindsey Schamp",
        "address": "Goudberg 49, 8530 Harelbeke",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "CVBA Bofidi Gent",
        "address": "Kortrijksesteenweg 1126A, 9051 Gent",
        "country": "BE",
        "legal_form": "CVBA"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Tiffany Sipli",
        "address": "Gereedstraat 5A, 9230 Wetteren",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "CVBA Bofidi Gent",
        "address": "Kortrijksesteenweg 1126A, 9051 Gent",
        "country": "BE",
        "legal_form": "CVBA"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Tuuli De Smet",
        "address": "Leihoekstraat 8, 9870 Machelen",
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "regular",
      "via_org": {
        "kbo": null,
        "name": "CVBA Bofidi Gent",
        "address": "Kortrijksesteenweg 1126A, 9051 Gent",
        "country": "BE",
        "legal_form": "CVBA"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Antwerpen",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": null,
    "filing_date": "2023-03-01",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decisions": [
    {
      "body": "algemene_vergadering",
      "date": "2023-01-27",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0653.744.366",
    "name_full": "FOX BIOSYSTEMS",
    "legal_form": "NAAMLOZE VENNOOTSCHAP"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Lindsey Schamp",
    "org_rep_person_name": null,
    "person_role_at_subject": "Gevolmachtigde"
  },
  "co_filed_documents": [
    "Annexes du Moniteur belge"
  ],
  "corrected_publication_numac": null
}

{
  "events": [
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": 864420.9,
      "delta_eur": 100000.0,
      "before_eur": 764420.9,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "de Limburgse Reconversie Maatschappij, afgekort LRM",
          "share_class": "bevoorrechte",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 14622,
          "contribution_amount_eur": 1104104.0
        }
      ],
      "share_emission": {
        "agio_eur": 1002338.1,
        "share_form": "no_nominal_value",
        "share_class": "bevoorrechte",
        "n_new_shares": 14622,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 75.51
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    },
    {
      "kind": "capital_increase",
      "after_eur": 1019420.9,
      "delta_eur": 155000.0,
      "before_eur": 864420.9,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "de commanditaire vennootschap Heran Healthtech Fund I",
          "share_class": "bevoorrechte",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 14622,
          "contribution_amount_eur": 1104104.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "de naamloze vennootschap Gemma Frisius-Fonds K.U.Leuven",
          "share_class": "bevoorrechte",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 2228,
          "contribution_amount_eur": 168244.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "de Katholieke Universiteit Leuven",
          "share_class": "bevoorrechte",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 3342,
          "contribution_amount_eur": 252367.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "de vennootschap naar het recht van het Verenigd Koninkrijk Cetromed",
          "share_class": "bevoorrechte",
          "liberation_pct": 100.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 2089,
          "contribution_amount_eur": 157729.0
        }
      ],
      "share_emission": {
        "agio_eur": 1527362.5,
        "share_form": "no_nominal_value",
        "share_class": "bevoorrechte",
        "n_new_shares": 22281,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 75.51
      },
      "decrease_purpose": null,
      "contribution_type": "inschrijvingsrechten_uitgifte",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    },
    {
      "kind": "capital_increase",
      "after_eur": 1195929.4,
      "delta_eur": 176508.5,
      "before_eur": 1019420.9,
      "subscribers": [
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "de commanditaire vennootschap Heran Healthtech Fund I",
          "share_class": "bevoorrechte",
          "liberation_pct": 75.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 16554,
          "contribution_amount_eur": 1250000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "de naamloze vennootschap Gemma Frisius-Fonds K.U.Leuven",
          "share_class": "bevoorrechte",
          "liberation_pct": 60.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 2649,
          "contribution_amount_eur": 200000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "de Katholieke Universiteit Leuven",
          "share_class": "bevoorrechte",
          "liberation_pct": 60.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 3973,
          "contribution_amount_eur": 300000.0
        },
        {
          "kbo": null,
          "rrn": null,
          "kind": "org",
          "name": "de naamloze vennootschap Limburgse Reconversie Maatschappij, afgekort LRM",
          "share_class": "bevoorrechte",
          "liberation_pct": 75.0,
          "contribution_kind": "geld",
          "n_shares_subscribed": 16554,
          "contribution_amount_eur": 1250000.0
        }
      ],
      "share_emission": {
        "agio_eur": 2723491.5,
        "share_form": "no_nominal_value",
        "share_class": "bevoorrechte",
        "n_new_shares": 39730,
        "with_new_shares": true,
        "nominal_value_eur": null,
        "issue_price_per_share_eur": 75.51
      },
      "decrease_purpose": null,
      "contribution_type": "geld",
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "create"
    },
    {
      "kind": "warrant_issuance",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "capital_increase",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": 1195929.4,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": 9519,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "share_class_creation",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    },
    {
      "kind": "statutory_reserve_release",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": "convert_to_distributable"
    },
    {
      "kind": "statutes_change",
      "after_eur": null,
      "delta_eur": null,
      "before_eur": null,
      "decrease_purpose": null,
      "contribution_type": null,
      "paid_up_delta_eur": null,
      "n_shares_destroyed": null,
      "not_yet_called_eur": null,
      "merger_new_shares_n": null,
      "merger_exchange_ratio": null,
      "distribution_amount_eur": null,
      "statutory_unavailable_equity_op": null
    }
  ],
  "notary": {
    "name": "Hugo Kuijpers",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Leuven-Heverlee",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2022-12-13",
    "filing_date": "2022-12-09",
    "act_kind_objet": "Onderwerp akte:"
  },
  "decision": {
    "body": "buitengewone_algemene_vergadering",
    "act_date": "2022-11-24",
    "unanimous": true,
    "under_authorized_capital": true,
    "underlying_resolution_date": "2022-11-24"
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0653.744.366",
    "name_full": "FOx Biosystems",
    "legal_form": "Naamloze vennootschap",
    "is_foreign_registered": false
  },
  "publication_proxy": {
    "kind": "none",
    "org_kbo": null,
    "org_name": null,
    "person_name": null,
    "org_rep_person_name": null,
    "person_role_at_subject": null
  },
  "co_filed_documents": [
    "uitgifte van het proces-verbaal van buitengewone algemene vergadering, met aanwezigheidslijst, volmachten, bijzonder verslag van het bestuursorgaan conform art. 7:180 WVV betreffende de uitgifte van inschrijvingsrechten en bijzonder verslag van het bestuursorgaan conform art. 43, \u00A73 en \u00A74 van de wet van 26 maart 1999 betreffende het Belgisch actieplan voor de werkgelegenheid 1998 en houdende diverse bepalingen",
    "bijzonder verslag van het bestuursorgaan conform art. 7:155 WVV betreffende de wijziging van rechten verbonden aan soorten van aandelen",
    "bijzonder verslag van het bestuursorgaan conform art. 7:179 en 7:197 WVV",
    "revisoraal verslag conform de uitgifte van inschrijvingsrechten en wijziging van rechten verbonden aan soorten van aandelen en beperking of opheffing van voorkeurrecht",
    "revisoraal verslag conform art. 7:179 en 7:197 WVV",
    "revisoraal verslag conform art. 43, \u00A74 van de wet van 26 maart 1999",
    "geco\u00F6rdineerde statuten"
  ],
  "shareholders_after": [
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "de Limburgse Reconversie Maatschappij, afgekort LRM",
      "role": "aandeelhouder",
      "n_shares": null,
      "share_class": "bevoorrechte"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "de commanditaire vennootschap Heran Healthtech Fund I",
      "role": "aandeelhouder",
      "n_shares": null,
      "share_class": "bevoorrechte"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "de naamloze vennootschap Gemma Frisius-Fonds K.U.Leuven",
      "role": "aandeelhouder",
      "n_shares": null,
      "share_class": "bevoorrechte"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "de Katholieke Universiteit Leuven",
      "role": "aandeelhouder",
      "n_shares": null,
      "share_class": "bevoorrechte"
    },
    {
      "kbo": null,
      "pct": null,
      "kind": "org",
      "name": "de vennootschap naar het recht van het Verenigd Koninkrijk Cetromed",
      "role": "aandeelhouder",
      "n_shares": null,
      "share_class": "bevoorrechte"
    }
  ],
  "share_classes_after": [
    {
      "n_shares": null,
      "class_name": "Gewone Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    },
    {
      "n_shares": null,
      "class_name": "Bevoorrechte Aandelen",
      "capital_share_eur": null,
      "voting_rights_per_share": 1.0
    }
  ]
}